Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Adc Therapeutics SA (ADCT)

115 + Investors. Track Smart Money conviction in ADCT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
4Q ▲
Buyers last Q
61%

Smart Money Signals — ADCT

Based on 116 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added ADCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
116 hedge funds hold ADCT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +40% more funds vs a year ago

fund count last 6Q
+33 new funds entered over the past year (+40% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 61% buying

71 buying46 selling
Last quarter: 71 funds were net buyers (19 opened a brand new position + 52 added to an existing one). Only 46 were sellers (29 trimmed + 17 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~19 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 14 → 22 → 21 → 19. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

47% of holders stayed for 2+ years

■ 47% conviction (2yr+) ■ 34% medium ■ 20% new
54 out of 116 hedge funds have held ADCT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +0%, value -89%

Value
-88%
Shares
+0%
Last quarter: funds added +0% more shares while total portfolio value only changed -89%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

14 → 14 → 22 → 21 → 19 new funds/Q
New funds entering each quarter: 14 → 22 → 21 → 19. A growing number of institutions are discovering ADCT each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 59% of holders stayed 2+ years

■ 59% veterans ■ 20% 1-2yr ■ 21% new
Of 120 current holders: 71 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 22% AUM from major funds

22% from top-100 AUM funds
34 of 116 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ADCT

In 2026 Q1, 71 hedge funds were net buyers of ADCT (19 opened a new position, 52 added to an existing one), while 46 reduced or exited (29 trimmed, 17 sold completely) — a 61% buyer ratio, indicating clear institutional accumulation. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 22% of total institutional value in ADCT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +2 funds (more new holders than closures). Total institutional holders: 116.

Hedge Fund Ownership: ADCT

How many hedge funds hold ADCT — quarterly history vs. share price
Quarterly hedge fund ownership of ADCT vs. share price

Market Analysis: ADCT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ADCT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Adc Therapeutics SA (ADCT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ADCT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
ADCT
-70.9%
XLV
+2.1%

ADCT outperformed XLV by -73.0% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
ADCT
-66.5%
XLV
+3.2%

Since the filing became public, ADCT outperformed XLV by -69.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 0 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
1.0
/ 10
conviction
Hedge Fund Positioning: ADCT
115 + Investors

Track Smart Money conviction in ADCT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 115 114 0.88%
13F Shares 83M 83M 0.49%
Total Value $310M $2.70B -88.52%
New Positions 18 21 -3
Increased Positions 52 47 +5
Closed Positions 17 11 +6
Reduced Positions 27 28 -1
Total Calls 4 2 100.0%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ADCT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

115 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ADCT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ADCT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Prosight Management, LP 5.10% 8,300,000 $31.1M
2 Redmile Group, LLC 3.84% 15,470,502 $58.0M
3 TCG Crossover Management, LLC 1.22% 11,390,175 $42.7M
4 Platinum Investment Management Ltd 0.94% 990,778 $3.7M
5 Nantahala Capital Management, LLC 0.77% 5,597,433 $21.0M
6 Blue Owl Capital Holdings LP 0.70% 733,568 $2.6M
7 Eventide Asset Management, LLC 0.35% 5,701,655 $21.4M
8 Orbimed Advisors LLC 0.10% 1,318,026 $4.9M
9 DAFNA Capital Management LLC 0.06% 72,081 $270K
10 Saxony Capital Management, LLC 0.05% 23,876 $90K
11 Voleon Capital Management LP 0.04% 513,831 $1.9M
12 DLK Investment Management, LLC 0.04% 25,305 $95K
13 Dynamic Technology Lab Private Ltd 0.03% 43,970 $165K
14 R Squared Ltd 0.02% 10,119 $38K
15 Kingswood Wealth Advisors, LLC 0.02% 105,107 $394K
16 Aviso Wealth Management 0.02% 10,343 $39K
17 Point72 Asset Management, L.P. 0.02% 3,382,129 $12.7M
18 Florida Trust Wealth Management Co 0.02% 150,435 $564K
19 Panagora Asset Management Inc 0.01% 691,275 $2.6M
20 Wilmington Savings Fund Society, FSB 0.01% 100,000 $375K
21 Cantor Fitzgerald, L. P. 0.01% 100,000 $375K
22 Millennium Management LLC 0.00% 3,119,154 $11.7M
23 Susquehanna Portfolio Strategies, LLC 0.00% 64,523 $242K
24 Graham Capital Management, L.P. 0.00% 22,442 $84K
25 Two Sigma Investments, LP 0.00% 668,022 $2.5M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Adc Therapeutics SA (ADCT)

What does the Smart Money Trend signal show for ADCT?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added ADCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ADCT?

More buyers than sellers — 61% buying: Last quarter: 71 funds were net buyers (19 opened a brand new position + 52 added to an existing one). Only 46 were sellers (29 trimmed + 17 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ADCT holders?

Strong quality — 22% AUM from major funds: 34 of 116 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ADCT?

47% of holders stayed for 2+ years: 54 out of 116 hedge funds have held ADCT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Adc Therapeutics SA (ADCT) following the 2026 Q1 hedge fund 13F filings?

As of today, ADCT has moved -66.5% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of -69.7%. Since the quarter end (March 31, 2026), ADCT has gained -70.9% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →